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Our knowledge of radiosensitivity of the different types of glioma and of what should be considered an adequate tumour dose has been greatly enriched during the last few years, mainly thanks to the research work of neurosurgeons, radiologists, and pathologists in the United States of America. We also know now more or less exactly the single dose of the X-rays which the brain can stand without subsequent ill-effects.
Experiments have definitely proved that the adult brain is one of the most radioresistant tissues of the body. Large doses of X-rays, however, such as used in the treatment of glioma, may produce microscopic vascular lesions, which usually do not produce clinical symptoms. On the other hand histological examination of the brain before and after irradiation has shown which of the gliomas are radiosensitive, the degree of their radiosensitiveness, and the effect of doses of different strengths.
Here is a table of the relative proportions of the most important types of glioma. The different types are arranged in order of their radiosensitiveness Type of tuimour Frequieincy of occulrrence (1) AlIedllloblastoma .. 13 0
(2) Ependymoma
3%0
(3) Astrocytoma ..37 (4) Glioblastoma multiforme 30% (5) Oligodendroglioma ..
4% (radioresistant)
Both clinical and pathological studies have proved that the most radiosensitive gliomas are the medulloblastomas, particularly the cerebellar medulloblastomas in children. In view, however, of the tendency of these tumours to form implantationmetastases along the subarachnoid system, the whole of the cerebrospinal axis should be irradiated. The results of occipital decompression to relieve hydrocephalis, followed by radiotherapy, are as good if not better than the results of removal of the growth.
Next in order of radiosensitiveness come the ependymomas. The tumour dose should be as large as compatible with skin tolerance and is in the neighbourhood of 4,000 r.
The astrocytomas, which form the largest group of cerebral gliomas, are relatively benign tumours, but are radiosensitive to a certain extent. Although the primary tumours may appear benign, the not-infrequent recurrences are often of a more malignant nature. Post-operative radiotherapy seems to counteract the tendency towards malignant recurrences.
The glioblastoma multiforme, this highly malignant glioma which no neurosurgeon wNould touch if he could help it, usually clinically benefits by the radiation, at least for a time. Thanks to irradiation the average post-operative survival has increased from about nine months to two years. The treatment must be intense and the intervals between successive courses of treatment short.
BRlood-vessel tumours, which represent about 2% of all intracranial tumours, can be divided into angiomatous malformations and haemangioblastomas, which are true tumouirs. Irradiation of inoperable tumours and post-operative irradiation following the removal of an hwemangioblastoma is definitely useful. Vascular imialformations should be treated by radiation rather than by excision. Even an audible bruit betraying an arteriovenous communication may disappear after irradiation. The radiation damages the vascular endothelium and causes thrombosis and obliteration of the vessels. Of the remaining types of glioma investigate(I the oligodendrogliomas, which are relatively benign tumours, are definitely radioresistant.
In a large number of cases radiotherapy is used in conjunction with a decompression or removal of the tumour and it is very difficult to assess exactly the degree of usefulness of the radiation. I should like, however, to quote two illustrative cases which were treated by radiation only. One, a patient of Dr. Yealland, a man aged 42, with a history of cerebral tumour dating from 1934. When he first came to the hospital in 1937 he complained of continual headache, which kept him awake at night, and of inability to walk owing to numbness and spasticity of left arm and leg. A radiograph of the skull showed an extensive destruction of the sella turcica, in this case the result of a long-standing increase of the intracranial pressure. A tumour of right pre-Rolandic area was diagnosed, and as the patient refused any surgical interference, it was decided to treat him by radiation. After the first course of treatment the headaches and paralysis disappeared and he was able to resume his work at the 92 1138 Woolwich Arsenal, w%rhere he has been working ever since, often as long as eleven hours a day. He has had several courses of X-ray treatment as an out-patient during the last two years and is having a course of treatment at the moment.
The other case, a patient of Dr. Worster-Drought, was a man aged 50, suffering from an intrapontine tumour. He was brought into my consulting room on a stretcher, paralysed and semiconscious. At the end of the course of X-ray treatment he was able to walk almost unaided the flight of stairs leading into my consulting room, and a month after the end of the treatment he was able to drive a car and mow the lawn.
In the greatest majority of cases, however, the growth sooner or later recurs. It can be kept in check by further courses of treatment, but a time necessarilv arrives when the scalp is unable to stand radiation any longer.
In such cases the direct irradiation of the tumour or tumour-bed in cases of removable tumour, may still be attempted. The tumour is exposed, the osteoplastic flap turned down, the area to be treated is covered with sterile cellophane, the scalp is covered with several layers of sterile thin lead foil, and the exposed area is given a dose of 3,000 to 6,000 r. Direct irradiation of the tumour or of the tumour bed with soft unfiltered radiation has recently been suggested as an alternative to the usual deep therapy through the closed skull.
I have not included meningiomas in this review because these tumours are definitely radioresistant, although various workers have reported favourable results from radiotherapy of meningiomas. I think that the good results are due to the secondary action of the radiation on the choroid plexuses and not to a direct effect on the tumour itself. Meningiomas are very slowly growing tumours and for this reason the cranial cavity gradually adapts itself to the increased intracranial pressure up to a point. A moment, however, arrives when the adaptation mechanism breaks down and the symptoms of tumour become acute. The radiation inhibits the choroid secretion and as a result less cerebrospinal fluid is produced. The intracranial tension slightly decreases, the circulation and consequently the absorption of the cerebrospinal fluid in the subarachnoid spaces improves. The improvement, however, lasts only until the adaptation mechanism irreparably breaks down again. In the meantime valuable time mayhave been lost and the operative risk become much greater. The craniopharyngiomas form a kind of logical link between the gliomas and pituitary adenomas. The operative mortality for these tumours is rather high.
One of the dangers of the radical operation in theease of moderately sized tumouirs is interference w-ith the thermo-regulating centre situated in the wall of the 3rd ventricle.
Thisinay result in a fatal hyperpyrexia. In view of this it has recently been suggested that the smaller tumours should be treated on more conservative lines. Only part of the cystic wall of the tumour (in case of cystic tumours) should be removed, and the operation should be followed by a course of radiotherapy, which prevents the re-accumulation of fluid in the cyst. This method of treatment seems to give better results than the more radical operation.
What are the ultimate results of radiotherapy in cases of glioma ? Here is a statistical survey by Cairns of post-operative survival of glioma operated at Of a series of 27 cases of cerebral tumour treated by Schinz in Zurich during 1919-1935, 16% were alive and well after five years.
There is therefore little difference between the ultimate results of the two methods of treatment, except for the bedraggled appearance of the patients who have been exposed to repeated intensive courses of radiotherapy. There is, however, no doubt that the final results in operable cases could be considerably improved by a combination of surgery and radiotherapy. Let 
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If there is practically unanimity between neurosurgeons and radiologists with regard to the respective merits of surgery and radiotherapy in tumours of the brain and meninges, no such unanimity exists in connexion with pituitary tumours. As recently as 1935 Cairns, in a paper on pituitary adenoma published in the Lancet, states that there is no evidence that radiotherapy is of any value in chromophobe adenoma, but he concedes that some acidophile adenomas are radiosensitive. This statement, while partly true, is somewhat misleading. We have no evidence that the radiation acts directly on the chromophobe cells of the adenoma, but there is both clinical and pathological evidence that in a large number of cases the adenoma shrinks following radiotherapy, possibly as a result of an obliteration of the bloodvessels.
Here is a summary of results of radiotherapy in seven cases of chromophobe adenoma as reported by Schnitker, Cutler, Bailey and Vaughan in an analysis of 81 cases of chromophobe adenoma treated by either radiation alone, or by operation alone, or by a combination of radiotherapy and surgery:
Visual improvement (100 0, being taken Statistics based on larger series of cases, however, show less favourable results. In deciding between operation and radiotherapy we have to consider four factors: (1) operative mortality, (2) chances of five years' survival, (3) stage of the disease, (4) chances of improvement of vision.
(1) The operative mortality in pituitary adenoma varies from one clinic to another. In Cushing's series the operative mortality for chromophobe adenoma was 3.8% and 10% for the eosinophile adenoma. In a recent article published in the British Medical Journal, Jefferson mentions 15 consecutive operations for pituitary adenoma without a single fatality. This is a remarkable record of which any neurosurgical clinic could be justly proud. But, on the other hand, some of the neurosurgical clinics report an appallingly high mortality of 30%. It would be equally fallacious to accept this as typical as it would the latest figures of Jefferson. In computing the results of the different clinics we arrive at a somewhat arbitrary figure of an average mortality of about 10%. The operative risks are therefore considerable, while the mortality from radiotherapy is pra'ctically nil.
(2) In the previously cited analysis of the results of operations for cranial tumour in the year 1926-27 carried out at Cushing's Clinic, Cairns reports 650/0 of the patients operated for pituitary adenomna surviving seven to nine years. In reviewing the results of radiotherapy in 5,000 cases of cancer Schinz, in a paper published in the last October issue of Strahlentherapie states that 60% of the patients treated by radiation for pituitary tumour w-ere alive and well after five years. Frolm this point of view there is therefore little to choose betNeen operation and radiation.
(3) The evolution of pituitary tuimours can be divided into three stages: the endocrine, ocular, and tuinoral.
There is probably complete agreement as to the treatment of the endocrine phase. The treatment should be bv radiation. But no hard and fast rules can be laid down, and should there be an encroachment on the visual fields in spite of repeated courses of radiation, the patient should be handed over to the surgeon. There is also complete agreement about the course of treatinent of the third or tumoral stage. Here it is no more a question of saving vision, but of saving life, and the treatment should be surgical in spite of increased operative risks. The choice of the best treatment for the second, ocular stage, brings us to factor (4) The question of restitution or preservation of eyesight. In the folloming 
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t is difficult to reconcile the post-irradiation results as shown here with those already quoted from the paper bv Schnitker, Cutler, Bailey and Vaughan. The last, however, as already mentioned, are not typical, being based on a too-small number of cases. Froim a carefuil perusal of the literature one gains the impression that chances of imiprovemient of vision are greater after operation than after treatment by radiation. This is due to several factors. In the first place about 15% of all pituitarv adenomas are cystic and X-ravs have Ino effect on suich tumnouirs. Then, a certain proportion of solid adenomias are definitelv radioresistant.
We can therefore suniiuinarize the position as follows: operative mortality about 10%, no mortality due to radiotherapy. Chances of five vears' survival approximately equal for either operation or radiotherapv. Chances of improvement of eyesight better after operation than after radiotherapy.
In view of this the proper poliev in all cases of pituitary adenoma, except in those cases which have reached the tuimoral phase or where there is the danger of a rapidly progressive loss of eyesight, the patients shotuld be given the chance of radiotherapy. The visual fields, however, muilst be controlled at frequent intervals and any nontransitory deterioration of eyesig,ht shouild call for an immiliediate operation. Transitory visual deterioration, lasting only a few days but follow-ed by an imnprovement of the eyesight, miay occur as a post-irradiative reaction.
The patients must be kept under proper ophthalmuological control for a considerable time after the irradiation. It has been our practice to repeat once or twice the course of treatment. Even repeatedl courses of irradiation do not in any way prejudice the results of a subsequient operation shouldI such an operation become necessarv.
Good results from radiotherapy have also been reported in dystrophia adiposogenitalis. Thus Kuipferle and Szily have treated 16 cases of dystrophia adiposogenitalis with the following results Improvement of eyesight in 13 cases ..
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Relief of dystrophy in 6 cases .. .. 37°G enital function not relieved in a sinmle case.
Recurrences after operation for pituitary adenoma occur in about 10% of cases.
It is mainly for this reason that post-operative radiotherapy has been advocated in all cases of pituitary adenoma. Post-operative radiotherapy seems also to improve the prognosis as regards eyesight, as can be seen from the following In the limited time at my disposal I have been able to give only a very cursory review of the subject. I hope, however, that the discussion will elucidate a number of points only briefly touched in this review.
Summary.-Most ofthe gliomas are radiosensitive, but the degree of radiosensitivity varies with the histological type in the descending order: medulloblastoma, ependymoma, astrocytoma, and glioblastoma multiforme. The oligodendroglioma is radioresistant. Of the blood-vessel tumours the haemangioblastomas should be treated by operation and post-operative irradiation, while the malformations should receive irradiation alone. The meningiomas are radioresistant tumours. As to pituitary adenomas, their evolution could be divided into three stages: (a) endocrine, (b) visual, and (c) tumoral. The endocrine phase should be treated by radiation, the tumoral phase by surgery, and the treatment of the visual phase should be determined by the circumstances. Patients undergoing radiotherapy should be closely watched and surgical intervention undertaken wAhen required. The best results follow combined treatment.
Mr. GEOFFREY JEFFERSON: There are two points in Mr. Orley's remarks which call especially for discussion. First the need for histological control of specimens from tumours which have had radiation. This is quite true, and there is no doubt that material exists in this country waiting for observations to be made on it. Possibly one reason why it has not been done is that the records of other observations-and they have been made especially in America-do not indicate that it is a very fruitful field for study. In actuality only a handful of cases have been examined anywhere, and even in those where the greatest clinical improvement has followed X-radiation, the medulloblastomas, the tumour obtained at the eventual necropsy has shown remarkably little difference from the structure of the original biopsy. It is evident from this work that the relief that patients gain (when they gain anything) -from post-operative X-ray treatment is due to a comnbination of factors, and that clear evidence of great alteration in tumour structure is not the only cause of this relief. Most clinicians will agree that radiotherapy has proved itself to be an advantage, and none will deny it to their patients in spite of the failure of scientific proof that it does a great deal to the tumour, so that the radiologist remains a valued partner.
The second point concerns the pituitary adenomas. I feel very strongly that operation and JULY-NEUR. 4* not ra(liation is the essentially sound method of treatment, and I should reverse Ir. Orley's in(lications, believing that the small tumours are the most favourable for operation and the large ones more suitable for X-ray therapy. The operation mortality of the small tumours is not more than 2 or 30o In one hundred operations on pituitary adenomas my own mortality is 70°,, most of the (leaths having occurred in the largest tumours. I have not found that much g)-ood follows radiation of the largest adenomas, those that one does not care to operate upon, and the probabilities are that they are not only dangerous to operate upon but impossible to cure by any means. I do not believe that it is wise to discuss this problem without reference to the visual fields, wsith the idea that pituitary adenomas could be schematized as all following one line of development and all appearing before the clinician at a uniform point in their development with the same visual changes in each. X-radiation seems to be the least use in the cases where one most wishes it to succeed, and that is a fact with a scientific meaning. It is not, however, a reason why we should stop trying
